Xconomy National

Archives

by in
Entry Author Date Location
Seattle Genetics Sees Updated Side Effect Warning in Drug Label Luke Timmerman 01/13/12 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs Luke Timmerman 08/22/11 National
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week Luke Timmerman 07/12/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul Luke Timmerman 07/05/11 Seattle
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News Luke Timmerman 03/03/11 Seattle
SEC Accuses Seattle Genetics Employee of Insider Trading Luke Timmerman 01/21/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market Luke Timmerman 01/14/11 Seattle
Editor’s Picks: The Best of 2010 From Xconomy Seattle Luke Timmerman 12/23/10 Seattle
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News Luke Timmerman 12/09/10 Seattle
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial Luke Timmerman 12/07/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s Luke Timmerman 12/05/10 Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer Luke Timmerman 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer Luke Timmerman 09/27/10 Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch Luke Timmerman 08/02/10 Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News Luke Timmerman 06/24/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News Luke Timmerman 06/11/10 Seattle
Seattle Genetics Shows Re-Treatment Action Luke Timmerman 06/05/10 Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug Luke Timmerman 05/26/10 Seattle
Seattle Genetics Adds Patent to 2025 Luke Timmerman 03/11/10 Seattle
Seattle Genetics Starts Lymphoma Trial Luke Timmerman 02/03/10 Seattle
Accelerator Slowed Down, Inside the Latest Seattle Genetics Deal, Ekos Finds New Use, & More Seattle-Area Life Sciences News Luke Timmerman 01/28/10 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News Luke Timmerman 10/15/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News Luke Timmerman 08/27/09 Seattle
Seattle Genetics Trial Fills Up Luke Timmerman 08/24/09 Seattle
Seattle Genetics Gets $136M Total Luke Timmerman 08/13/09 Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed Luke Timmerman 08/12/09 Seattle
Seattle Genetics Starts New Trial Luke Timmerman 06/18/09 Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News Luke Timmerman 06/04/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results Luke Timmerman 06/01/09 Seattle
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study Luke Timmerman 06/01/09 Seattle
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.